A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

200886 citationsJournal Article

Authors

Ramosetron is an effective and well-tolerated treatment not only for female IBS patients but also for male patients.

Good health and well-being

Published in: Digestion

Volume 77, Issue 3-4, pp. 225-235

Field-Weighted Citation Impact: 4.92